Skip to content

Active Digital Management (Wei-Zhi-Chan Model) versus Passive Surveillance in Atrial Fibrillation: A Population-Based, Parallel-Cohort Real-World Study

Active Digital Management (Wei-Zhi-Chan Model) versus Passive Surveillance in Atrial Fibrillation: A Population-Based, Parallel-Cohort Real-World Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120942
Enrollment
Unknown
Registered
2026-03-23
Start date
2026-03-25
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Interventions

Active Intervention Group:Accept the "Weizhi Chuan" full-process closed-loop management. It includes: (1) Intelligent screening: home card-based ECG monitoring and risk warning
(2) AI-assisted diagnosis and treatment: AI-assisted diagnosis and CDSS decision support on the doctor's end (automatic score calculation, recommended anticoagulant regimen)
(3) Full-course management: 24-hour consultation with AI digital doctors, AI robot voice follow-up, and a green channel for graded referral.
Passive Control Group:The patient receives routine medical services. The patient seeks medical care on their own according to their usual habits and receives local routine diagnosis and treatment. The

Sponsors

Weifang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age: >= 18 years old; 2. Diagnosis: Confirmed as atrial fibrillation (ICD-10 code: I48) in any medical institution in Weifang City from January 1, 2023 to December 31, 2024, or indicated by electrocardiogram/Holter monitoring; 3. Permanent residents: Those with medical insurance records or public health files in Weifang City and at least one medical contact record in the past three years to ensure the traceability of baseline data.

Exclusion criteria

Exclusion criteria: 1. Valvular atrial fibrillation: Patients with moderate to severe mitral stenosis or those who have undergone mechanical valve replacement; 2. Limited life expectancy: Life expectancy < 1 year (such as patients with advanced malignant tumors); 3. Compliance disorder: Those with a history of severe mental illness and unable to cooperate with active management (only applicable for exclusion in the intervention group).

Design outcomes

Primary

MeasureTime frame
Incidence of new ischemic stroke or systemic embolism;All-cause Mortality;

Secondary

MeasureTime frame
Cardiovascular Mortality;Re-hospitalization rate of heart failure;Quality of life score;

Countries

China

Contacts

Public ContactChen Yanbo

Weifang People's Hospital

cyb0222@126.com+86 151 6646 0788

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026